المؤلفون: Whisenant, J.G., Baena, J., Cortellini, A., Huang, L.C., Lo Russo, G., Porcu, L., Wong, S.K., Bestvina, C.M., Hellmann, M.D., Roca, E., Rizvi, H., Monnet, I., Boudjemaa, A., Rogado, J., Pasello, G., Leighl, N.B., Arrieta, O., Aujayeb, A., Batra, U., Azzam, A.Y., Unk, M., Azab, M.A., Zhumagaliyeva, A.N., Gomez-Martin, C., Blaquier, J.B., Geraedts, E., Mountzios, G., Serrano-Montero, G., Reinmuth, N., Coate, L., Marmarelis, M., Presley, C.J., Hirsch, F.R., Garrido, P., Khan, H., Baggi, A., Mascaux, C., Halmos, B., Ceresoli, G.L., Fidler, M.J., Scotti, V., Métivier, A.C., Falchero, L., Felip, E., Genova, C., Mazieres, J., Tapan, U., Brahmer, J., Bria, E., Puri, S., Popat, S., Reckamp, K.L., Morgillo, F., Nadal, E., Mazzoni, F., Agustoni, F., Bar, J., Grosso, F., Avrillon, V., Patel, J.D., Gomes, F., Ibrahim, E., Trama, A., Bettini, A.C., Barlesi, F., Dingemans, A.M., Wakelee, H., Peters, S., Horn, L., Garassino, M.C., Torri, V.

المساهمون: TERAVOLT study group

المصدر: Journal of thoracic oncology, vol. 17, no. 5, pp. 661-674

مصطلحات موضوعية: C-Reactive Protein, COVID-19, COVID-19 Testing, Humans, Lung Neoplasms/diagnosis, Prognosis, Registries, Retrospective Studies, SARS-CoV-2, Thoracic Neoplasms/diagnosis, Cancer, NSCLC, Registry, TERAVOLT, Thoracic

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35121086; info:eu-repo/semantics/altIdentifier/eissn/1556-1380; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_8A000CE084973; https://serval.unil.ch/notice/serval:BIB_8A000CE08497Test; urn:issn:1556-0864; https://serval.unil.ch/resource/serval:BIB_8A000CE08497.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_8A000CE084973Test

الإتاحة: https://doi.org/10.1016/j.jtho.2021.12.015Test
https://serval.unil.ch/notice/serval:BIB_8A000CE08497Test
https://serval.unil.ch/resource/serval:BIB_8A000CE08497.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_8A000CE084973Test

المؤلفون: Bestvina, C.M., Whisenant, J.G., Torri, V., Cortellini, A., Wakelee, H., Peters, S., Roca, E., De Toma, A., Hirsch, F.R., Mamdani, H., Halmos, B., Arrieta, O., Metivier, A.C., Fidler, M.J., Rogado, J., Presley, C.J., Mascaux, C., Genova, C., Blaquier, J.B., Addeo, A., Finocchiaro, G., Khan, H., Mazieres, J., Morgillo, F., Bar, J., Aujayeb, A., Mountzios, G., Scotti, V., Grosso, F., Geraedts, E., Zhumagaliyeva, A.N., Horn, L., Garassino, M.C., Baena, J.

المساهمون: TERAVOLT study group

المصدر: JTO clinical and research reports, vol. 3, no. 8, pp. 100335

مصطلحات موضوعية: COVID-19, Cancer, NSCLC, Registry, TERAVOLT, Thoracic

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35619644; info:eu-repo/semantics/altIdentifier/eissn/2666-3643; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_EBBB31952F9C8; https://serval.unil.ch/notice/serval:BIB_EBBB31952F9CTest; urn:issn:2666-3643; https://serval.unil.ch/resource/serval:BIB_EBBB31952F9C.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_EBBB31952F9C8Test

الإتاحة: https://doi.org/10.1016/j.jtocrr.2022.100335Test
https://serval.unil.ch/notice/serval:BIB_EBBB31952F9CTest
https://serval.unil.ch/resource/serval:BIB_EBBB31952F9C.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_EBBB31952F9C8Test

المؤلفون: Pizzutilo, E G, Agostara, A G, Oresti, S, Signorelli, D, Stabile, S, Lauricella, C, Motta, V, Amatu, A, Ruggieri, L, Brambilla, M, Occhipinti, M, Proto, C, Giusti, R, Filetti, M, Genova, C, Barletta, G, Gelsomino, F, Bennati, C, Siringo, M, Di Fazio, G R, Russano, M, Montrone, M, Gariazzo, E, Roca, E, Bordi, P, Delmonte, A, Scimone, A, Belluomini, L, Mazzoni, F, Carta, A, Pelizzari, G, Viscardi, G, Morgillo, F, Gelibter, A, Gori, S, Berardi, R, Cortinovis, D, Ardizzoni, A, Veronese, S M, Sartore-Bianchi, A, Giannetta, L G, Cerea, G, Siena, S

المصدر: ESMO Open ; ISSN:2059-7029 ; Volume:9 ; Issue:6

مصطلحات موضوعية: NSCLC, atypical EGFR, compound mutations, osimertinib, uncommon EGFR mutations

العلاقة: https://doi.org/10.1016/j.esmoop.2024.103592Test; https://pubmed.ncbi.nlm.nih.gov/38878323Test

الإتاحة: https://doi.org/10.1016/j.esmoop.2024.103592Test
https://pubmed.ncbi.nlm.nih.gov/38878323Test

المؤلفون: Fasano M., Della Corte C. M., Di Liello R., Barra G., Sparano F., Viscardi G., Iacovino M. L., Paragliola F., Famiglietti V., Ciaramella V., Cimmino F., Capasso M., Iolascon A., Sforza V., Morabito A., Maiello E., Ciardiello F., Morgillo F.

المساهمون: Fasano, M., Della Corte, C. M., Di Liello, R., Barra, G., Sparano, F., Viscardi, G., Iacovino, M. L., Paragliola, F., Famiglietti, V., Ciaramella, V., Cimmino, F., Capasso, M., Iolascon, A., Sforza, V., Morabito, A., Maiello, E., Ciardiello, F., Morgillo, F.

مصطلحات موضوعية: ADCC, avelumab, cetuximab, NK cell, NSCLC

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000572159000002; volume:5; issue:5; firstpage:e000753; journal:ESMO OPEN; http://hdl.handle.net/11588/830133Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85090820835

الإتاحة: https://doi.org/10.1136/esmoopen-2020-000753Test
http://hdl.handle.net/11588/830133Test

المؤلفون: Morabito A., Piccirillo M. C., Maione P., Luciani A., Cavanna L., Bonanno L., Filipazzi V., Leo S., Cinieri S., Morgillo F., Burgio M. A., Ferrara D., Rosetti F., Bianco R., Artioli F., Cortinovis D., Gebbia V., Fregoni V., Mencoboni M., Sandomenico C., Rossi A., Montanino A., Manzo A., Rocco G., Arenare L., Daniele G., Signoriello S., Gallo C., Perrone F., Gridelli C.

المساهمون: Morabito, A., Piccirillo, M. C., Maione, P., Luciani, A., Cavanna, L., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Morgillo, F., Burgio, M. A., Ferrara, D., Rosetti, F., Bianco, R., Artioli, F., Cortinovis, D., Gebbia, V., Fregoni, V., Mencoboni, M., Sandomenico, C., Rossi, A., Montanino, A., Manzo, A., Rocco, G., Arenare, L., Daniele, G., Signoriello, S., Gallo, C., Perrone, F., Gridelli, C.

مصطلحات موضوعية: Cisplatin, Elderly patient, NSCLC, Phase 3, Quality of life, Randomized, Aged, 80 and over, Alopecia, Antineoplastic Combined Chemotherapy Protocol, Carcinoma, Non-Small-Cell Lung, Female, Human, Lung Neoplasm, Male, Neoplasm Staging, Stomatitis, Aphthou, Surveys and Questionnaire, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000474326700011; volume:133; firstpage:62; lastpage:68; numberofpages:7; journal:LUNG CANCER; http://hdl.handle.net/11588/823694Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85065520913

الإتاحة: https://doi.org/10.1016/j.lungcan.2019.05.009Test
http://hdl.handle.net/11588/823694Test

المؤلفون: Della Corte C. M., Morgillo F.

المساهمون: Della Corte, C. M., Morgillo, F.

مصطلحات موضوعية: immunotherapy, NSCLC, steroid, T-lymphocytes

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30964127; info:eu-repo/semantics/altIdentifier/wos/WOS:000468579500006; volume:4; issue:1; firstpage:e000477; journal:ESMO OPEN; http://hdl.handle.net/11591/424045Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85062427070; esmoopen.bmj.com/

الإتاحة: https://doi.org/10.1136/esmoopen-2018-000477Test
http://hdl.handle.net/11591/424045Test

المؤلفون: Morgillo F, Fasano M, Della Corte CM, Sasso FC, Papaccio F, Viscardi G, Esposito G, Di Liello R, Normanno N, Capuano A, Berrino L, Vicidomini G, Fiorelli A, Santini M, Ciardiello F.

المساهمون: Morgillo, F, Fasano, M, Della Corte, Cm, Sasso, Fc, Papaccio, F, Viscardi, G, Esposito, G, Di Liello, R, Normanno, N, Capuano, A, Berrino, L, Vicidomini, G, Fiorelli, A, Santini, M, Ciardiello, F.

مصطلحات موضوعية: LKB1, NSCLC, Erlotinib, Metformin

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28761738; info:eu-repo/semantics/altIdentifier/wos/WOS:000408040300001; volume:2; firstpage:1; lastpage:7; numberofpages:7; journal:ESMO OPEN; https://hdl.handle.net/11386/4752925Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85043486943; https://www.sciencedirect.com/science/article/pii/S2059702920324431?via=ihubTest

الإتاحة: https://doi.org/10.1136/esmoopen-2016-000132Test
https://hdl.handle.net/11386/4752925Test
https://www.sciencedirect.com/science/article/pii/S2059702920324431?via=ihubTest

المؤلفون: Della Corte C. M., Ciaramella V., Di Mauro C., Castellone M. D., Papaccio F., Fasano M., Sasso F. C., Martinelli E., Troiani T., De Vita F., Orditura M., Bianco R., Ciardiello F., Morgillo F.

المساهمون: Della Corte, C. M., Ciaramella, V., Di Mauro, C., Castellone, M. D., Papaccio, F., Fasano, M., Sasso, F. C., Martinelli, E., Troiani, T., De Vita, F., Orditura, M., Bianco, R., Ciardiello, F., Morgillo, F.

مصطلحات موضوعية: MEK, Metformin, NSCLC, Pimasertib, Selumetinib, Animal, Antineoplastic Combined Chemotherapy Protocol, Apoptosi, Benzimidazole, Blotting, Western, Carcinoma, Non-Small-Cell Lung, Cell Proliferation, Chromatin Immunoprecipitation, Female, Gene Expression Regulation, Neoplastic, Human, Hypoglycemic Agent, Immunoenzyme Technique, Lung Neoplasm, MAP Kinase Kinase 1, Mice, Inbred BALB C, Nude, Niacinamide, Protein Kinase Inhibitor, Protein-Serine-Threonine Kinase, Transcription Factor

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26673006; info:eu-repo/semantics/altIdentifier/wos/WOS:000369952400046; volume:7; issue:4; firstpage:4265; lastpage:4278; numberofpages:14; journal:ONCOTARGET; http://hdl.handle.net/11591/431910Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84958019588; http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&pathTest[]=6559&path[]=18508

الإتاحة: https://doi.org/10.18632/oncotarget.6559Test
http://hdl.handle.net/11591/431910Test
http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&pathTest[]=6559&path[]=18508

المؤلفون: Di Maio, M, Leighl, Nb, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, Ms, Signoriello, S, Perrone, F, Gridelli, C, Torch, Investigators, Calabro', L

المساهمون: Di Maio, M., Leighl, N. B., Gallo, C., Feld, R., Ciardiello, F., Butts, C., Maione, P., Gebbia, V., Morgillo, F., Wierzbicki, R., Favaretto, A., Alam, Y., Cinieri, S., Siena, S., Bianco, Roberto, Riccardi, F., Spatafora, M., Ravaioli, A., Felletti, R., Fregoni, V., Genestreti, G., Rossi, A., Mancuso, G., Fasano, M., Morabito, A., Tsao, M. S., Signoriello, S., Perrone, F., Gridelli, C., Di Maio, M, Leighl, N, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, M, Signoriello, S, Perrone, F, Gridelli, C, Leighl, Nb

مصطلحات موضوعية: Oncology, Male, erlotinib, Lung Neoplasms, Health-related quality of life, NSCLC, chemotherapy, Deoxycytidine, law.invention, Randomized controlled trial, Quality of life, law, Carcinoma, Non-Small-Cell Lung, Surveys and Questionnaires, Antineoplastic Combined Chemotherapy Protocols, Surveys and Questionnaire, Quality of life analysis of TORCH, Erlotinib Hydrochloride, Prognosis, humanities, Research Design, Advanced non–small-cell lung cancer, Carcinoma, Squamous Cell, Female, Erlotinib, Randomized trial, medicine.drug, Human, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Prognosi, EGFR, First-line treatment, first-line erlotinib, second-line cisplatin/gemcitabine chemotherapy, Adenocarcinoma, NO, Follow-Up Studie, Internal medicine, advanced non-small-cell lung cancer, medicine, Humans, Lung cancer, Advanced non-small-cell lung cancer, Chemotherapy, Quality of life analysis of TORCH , first-line erlotinib , second-line cisplatin/gemcitabine chemotherapy, advanced non-small-cell lung cancer, Aged, Neoplasm Staging, Salvage Therapy, Antineoplastic Combined Chemotherapy Protocol, business.industry, Questionnaire, Cancer, Quinazoline, medicine.disease, Interim analysis, Gemcitabine, Surgery, Lung Neoplasm, quality of life, Quinazolines, Carcinoma, Large Cell, Cisplatin, Neoplasm Recurrence, Local, business, Follow-Up Studies

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::297e0496785c9c52225a929dbddaa27eTest
http://hdl.handle.net/11588/519780Test

المؤلفون: Gridelli C, Ciardiello F, Gallo C, Feld R, Butts C, Gebbia V, Maione P, Morgillo F, Genestreti G, Favaretto A, Leighl N, Wierzbicki R, Cinieri S, Alam Y, Siena S, Felletti R, Riccardi F, Mancuso G, Rossi A, Cantile F, Tsao M. S, Saieg M, da Cunha Santos G, Piccirillo MC, Di Maio M, Morabito A, Perrone F., TORTORA, GIAMPAOLO

المساهمون: Gridelli, C, Ciardiello, F, Gallo, C, Feld, R, Butts, C, Gebbia, V, Maione, P, Morgillo, F, Genestreti, G, Favaretto, A, Leighl, N, Wierzbicki, R, Cinieri, S, Alam, Y, Siena, S, Tortora, Giampaolo, Felletti, R, Riccardi, F, Mancuso, G, Rossi, A, Cantile, F, Tsao, M. S., Saieg, M, da Cunha Santos, G, Piccirillo, Mc, Di Maio, M, Morabito, A, Perrone, F.

مصطلحات موضوعية: NSCLC, Erlotinib, Chemotherapy

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/22778317; info:eu-repo/semantics/altIdentifier/wos/WOS:000308082300016; volume:30; issue:24; firstpage:3002; lastpage:3011; numberofpages:10; journal:JOURNAL OF CLINICAL ONCOLOGY; http://hdl.handle.net/11562/429761Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84865154870

الإتاحة: http://hdl.handle.net/11562/429761Test